Compare EL & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EL | WST |
|---|---|---|
| Founded | 1946 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.3B | 18.5B |
| IPO Year | 2007 | 2004 |
| Metric | EL | WST |
|---|---|---|
| Price | $84.81 | $327.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 7 |
| Target Price | $97.60 | ★ $325.86 |
| AVG Volume (30 Days) | ★ 3.5M | 601.6K |
| Earning Date | 05-01-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.85% | 0.30% |
| EPS Growth | N/A | ★ 1.49 |
| EPS | 0.82 | ★ 1.92 |
| Revenue | ★ $14,326,000,000.00 | $2,886,900,000.00 |
| Revenue This Year | $7.51 | $6.76 |
| Revenue Next Year | $4.08 | $6.22 |
| P/E Ratio | ★ $103.51 | $170.83 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $66.22 | $206.80 |
| 52 Week High | $121.64 | $336.82 |
| Indicator | EL | WST |
|---|---|---|
| Relative Strength Index (RSI) | 50.12 | 59.15 |
| Support Level | $83.82 | $253.53 |
| Resistance Level | $91.06 | $333.85 |
| Average True Range (ATR) | 3.09 | 7.33 |
| MACD | -0.30 | -0.64 |
| Stochastic Oscillator | 34.17 | 68.40 |
Estée Lauder is a leader in the global prestige beauty market, participating across skin care (49% of fiscal 2025 sales), makeup (29%), fragrance (17%), and hair care and others (5%). Top-selling brands include Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 31% of revenue from the Americas, 37% from Europe, the Middle East and Africa (including travel retail), and 32% from Asia-Pacific. Estée Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.